BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

462 related articles for article (PubMed ID: 30220545)

  • 1. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA deficiency disrupts podocyte cytoskeleton and induces podocyte apoptosis by inhibiting YAP/dendrin signal.
    Huang Z; Zhang L; Chen Y; Zhang H; Yu C; Zhou F; Zhang Z; Jiang L; Li R; Ma J; Li Z; Lai Y; Lin T; Zhao X; Zhang Q; Zhang B; Ye Z; Liu S; Wang W; Liang X; Liao R; Shi W
    BMC Nephrol; 2016 Jul; 17(1):66. PubMed ID: 27389190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Astragaloside IV protects against podocyte apoptosis by inhibiting oxidative stress via activating PPARγ-Klotho-FoxO1 axis in diabetic nephropathy.
    Xing L; Fang J; Zhu B; Wang L; Chen J; Wang Y; Huang J; Wang H; Yao X
    Life Sci; 2021 Mar; 269():119068. PubMed ID: 33476631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Septin 7 mediates high glucose-induced podocyte apoptosis.
    Li R; Dong W; Zhang S; Yang H; Zhang L; Ye Z; Zhao X; Zhang H; Li Z; Xu L; Liu S; Shi W; Liang X
    Biochem Biophys Res Commun; 2018 Nov; 506(3):522-528. PubMed ID: 30361092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of transcriptional coactivator YAP Impairs the expression and function of transcription factor WT1 in diabetic podocyte injury.
    Chen J; Wang X; He Q; Yang HC; Fogo AB; Harris RC
    Kidney Int; 2024 Jun; 105(6):1200-1211. PubMed ID: 38423183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.
    Zhang L; Li R; Shi W; Liang X; Liu S; Ye Z; Yu C; Chen Y; Zhang B; Wang W; Lai Y; Ma J; Li Z; Tan X
    Br J Pharmacol; 2013 Sep; 170(2):426-39. PubMed ID: 23826864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes.
    Xing L; Guo H; Meng S; Zhu B; Fang J; Huang J; Chen J; Wang Y; Wang L; Yao X; Wang H
    Biochem Biophys Res Commun; 2021 Jan; 534():450-456. PubMed ID: 33256980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissection of Glomerular Transcriptional Profile in Patients With Diabetic Nephropathy: SRGAP2a Protects Podocyte Structure and Function.
    Pan Y; Jiang S; Hou Q; Qiu D; Shi J; Wang L; Chen Z; Zhang M; Duan A; Qin W; Zen K; Liu Z
    Diabetes; 2018 Apr; 67(4):717-730. PubMed ID: 29242313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
    Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin β3 overexpression contributes to podocyte injury through inhibiting RhoA/YAP signaling pathway.
    Li Z; Lian Z; Ma J; Zhang L; Lian X; Liu S; Xie J; Feng Z; Lin T; Zhang H; Liang X
    Bioengineered; 2021 Dec; 12(1):1138-1149. PubMed ID: 33818281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
    Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
    J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
    [No Abstract]   [Full Text] [Related]  

  • 14. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.
    Susztak K; Raff AC; Schiffer M; Böttinger EP
    Diabetes; 2006 Jan; 55(1):225-33. PubMed ID: 16380497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet Transplantation Reverses Podocyte Injury in Diabetic Nephropathy or Induced by High Glucose via Inhibiting RhoA/ROCK/NF-
    Huang C; Zhou Y; Huang H; Zheng Y; Kong L; Zhang H; Zhang Y; Wang H; Yang M; Xu X; Chen B
    J Diabetes Res; 2021; 2021():9570405. PubMed ID: 33778085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sam68 mediates high glucose‑induced podocyte apoptosis through modulation of Bax/Bcl‑2.
    Chen Y; Zhang L; Liu S; Yao B; Zhang H; Liang S; Ma J; Liang X; Shi W
    Mol Med Rep; 2019 Oct; 20(4):3728-3734. PubMed ID: 31485651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-188-3p abolishes germacrone-mediated podocyte protection in a mouse model of diabetic nephropathy in type I diabetes through triggering mitochondrial injury.
    Wang Y; Feng F; He W; Sun L; He Q; Jin J
    Bioengineered; 2022 Jan; 13(1):774-788. PubMed ID: 34847832
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway.
    Huang Z; Zhang L; Chen Y; Zhang H; Zhang Q; Li R; Ma J; Li Z; Yu C; Lai Y; Lin T; Zhao X; Zhang B; Ye Z; Liu S; Wang W; Liang X; Liao R; Shi W
    Cell Death Dis; 2016 Mar; 7(3):e2142. PubMed ID: 26986510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-770-5p is involved in the development of diabetic nephropathy through regulating podocyte apoptosis by targeting TP53 regulated inhibitor of apoptosis 1.
    Zhang SZ; Qiu XJ; Dong SS; Zhou LN; Zhu Y; Wang MD; Jin LW
    Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1248-1256. PubMed ID: 30779094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.